Latest News Archive
Please select Category, Year, and then Month to display items
23 April 2020
|
Story Cornelius Hagenmeier
|
Photo Pixabay
The iKudu project, which is an European Union-funded Capacity Building in Higher Education (CBHE) project, has recently launched its blog, which aims to amplify the diverse voices of all iKudu stakeholders. In this space, members of the iKudu team will regularly share their views on the project and related international education topics.
The iKudu project focuses on developing a contextualised South African concept of Internationalisation of the Curriculum (IoC), which integrates Cooperative Online International Learning (COIL) virtual exchanges. The project was launched by the UFS in 2019, together with nine European and South African partner universities. It is funded by the European Union’s Erasmus+ programme with EUR999 881 (approximately R20 million) and is implemented over a three-year period.
The iKudu project is based on the fundamental belief that it is necessary to rethink internationalisation in an uncertain world. First, it is crucial to recognise and transform the power dynamics underlying international academic collaboration. Second, it is essential to develop pedagogies that allow every student to participate in international education, integrating technology where appropriate.
However, while all stakeholders agree on the fundamental tenets of the project and its principal goals, all iKudu stakeholders contribute different perspectives. In the blog, the iKudu stakeholders will provide a space for intellectual discourse on the project and related international education topics, which will allow constructive and critical engagement.
The link to the blog can be found at: https://www.ufs.ac.za/ikudu/ikudu-blogs/Transforming-Curricula-through-Internationalisation-and-Virtual-Exchanges
DNA sequencer launched at the UFS
2013-11-25
 |
| Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them. |
The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.
The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.
The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.
The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.
The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.
“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.
Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”